Becton Dickinson and Co
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
446 / 663
Position in country
10778 / 14179
Return on Assets, %
2.4
-11.9
Net income margin, %
5.9
-12.5
EBITDA margin, %
22.8
-2.5
Debt to Equity, %
63.5
15
Intangible assets and goodwill, %
67.3
3.9
Revenue CAGR 3Y, %
6.4
12.6
Total Equity change 1Y, %
-0.6
0
Revenue Y, % chg
4
4.6
P/E
53.6
28.3
P/BV
2.6
1.7
P/S
3.4
3.7
EV/S
4.2
3.2
EV/EBITDA
17.4
-0.2
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
19
66.5
Forward P/E
17.1
19.2
Dividend Yield, %
1.6
1.8
Forward Dividend Yield, %
1.6
0.2
Expected dividend per share
3.8
0
Payout Ratio, %
83.9
17.3
Dividend Ex Date
2024-03-07
Competitors
Ranks
-
Dexcom Inc
00%
-
Boston Scientific Corp
00%
-
Intuitive Surgical Inc
00%
-
Stryker Corp
00%
-
Edwards Lifesciences Corp
00%
-
IDEXX Laboratories Inc
00%
-
Abbott Laboratories
00%
-
GE Healthcare Technologies Inc
00%
-
Hologic Inc
00%
-
Becton Dickinson and Co
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
67941.1
Ticker
BDX.N
ISIN
US0758871091
IPO date
1963-09-25
Availability on Russian exchanges
Yes
Reporting for
2024-02-01
Date fact. publication of reports
2023-12-31
Company Description
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: